Document is current
Any future updates will be listed below
-
Authors
Pan, Li-Xin http://orcid.org/0000-0002-3491-5095
Wang, Yi-Yang
Li, Zhong-Hai
Luo, Jia-Xi
Wu, Kun-Jun
Liu, Zhen-Xiu
Wu, Pei-Sheng
Chen, Kang
Ma, Liang
Fan, Xiao-Hui
Zhong, Jian-Hong http://orcid.org/0000-0002-1494-6396
-
Funding
Funding for this research was provided by:
Specific Research Project of Guangxi for Research Bases and Talents (GuiKe AD22035057)
National Natural Science Foundation of China (82060510, 82260569)
Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumors (Guangxi Medical University) at the Ministry of Education (GKE-ZZ202217, GKE-ZZ202311)
- License Information
-
More Information
Article History
Received: 11 July 2023
Accepted: 22 October 2023
First Online: 5 January 2024
Declarations
:
: This study will adhere to the Helsinki Declaration as revised in 2000 and to institutional and national regulations in China [CitationRef removed]. This trial protocol was reviewed and approved by the Ethics Committee of Guangxi Medical University Cancer Hospital [reference number CS2021(74)]. All participants will sign informed consent prior to inclusion in the study.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request. When signing the informed consent, all participants will be informed that the relevant data will be compiled and published after the end of the study.
: No sponsors were involved in this study. The authors declare no conflicts of interest relevant to the content of this article.
